Literature DB >> 15798786

Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene.

Maryvonne Le Saux1, Thérèse Di Paolo.   

Abstract

OBJECTIVE: It is thought that an imbalance in serotonergic neurotransmission may underlie many affective disorders. Thus, the serotonin-1A (5-HT1A) receptor is a target for antidepressant and neuroleptic drugs. It has been reported that estrogens modulate serotonergic neurotransmission. Therefore, we investigated the effect of long-term ovariectomy on 5-HT1A receptor-specific binding and G-protein activation in the brain. Correction therapy with estradiol was compared with treatments using the selective estrogen receptor modulators tamoxifen and raloxifene.
METHODS: Four months after ovariectomy, Sprague-Dawley rats were treated with vehicle, 17beta-estradiol (80 microg/kg), tamoxifen (1 mg/kg) or raloxifene (1 mg/kg) subcutaneously for 2 weeks. Specific binding to 5-HT1A receptors was assessed by autoradiography of brain sections using the 5-HT1A agonist [3H]8-OH-DPAT. 5-HT1A receptor stimulation was measured using R-(+)-8-OH-DPAT-stimulated [35S]GTPgammaS-binding autoradiography.
RESULTS: Ovariectomy decreased uterine weight, which was corrected by estradiol; tamoxifen and raloxifene partially corrected this decrease. Hormonal withdrawal and replacement left [3H]8-OH-DPAT-specific binding unchanged in the cortex. In contrast, ovariectomy induced a decrease in R-(+)-8-OH-DPAT-stimulated [35S]GTPgammaS-specific binding in the cortex; this was corrected by estradiol but was not corrected significantly by tamoxifen or raloxifene. In the hippocampus, ovariectomy had no effect on [3H]8-OH-DPAT-specific binding, whereas only 17beta-estradiol treatment decreased this binding in a subregion of the CA3. Ovariectomy increased R-(+)-8-OH-DPAT-stimulated [35S]GTPgammaS-specific binding in the dentate gyrus (but not in the CA1 or CA3); this was corrected by estradiol and raloxifene, but not by tamoxifen. In the dorsal raphe nucleus, ovariectomy increased [3H]8-OH-DPAT-specific binding and R-(+)-8-OH-DPAT-stimulated [35S]GTPgammaS-specific binding; estradiol corrected this increase, but this was not corrected significantly by tamoxifen or raloxifene.
CONCLUSIONS: An overall stimulation by estradiol of 5-HT1A receptor-specific binding and coupling was observed, decreasing raphe somatodendritic receptors and increasing cortical postsynaptic receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15798786      PMCID: PMC551165     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  57 in total

Review 1.  The menopausal transition: characteristics and management.

Authors:  Gregory Zapantis; Nanette Santoro
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2003-03       Impact factor: 4.690

2.  Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor.

Authors:  Michelle Landry; Thérèse Di Paolo
Journal:  Brain Res Mol Brain Res       Date:  2003-04-10

3.  Estrogen enhances a 5-HT1A response in hippocampal slices from female rats.

Authors:  W P Clarke; J Goldfarb
Journal:  Eur J Pharmacol       Date:  1989-01-24       Impact factor: 4.432

4.  Chronic estrogen effects on 5-hydroxytryptamine-mediated responses in hippocampal pyramidal cells of female rats.

Authors:  S G Beck; W P Clarke; J Goldfarb
Journal:  Neurosci Lett       Date:  1989-11-20       Impact factor: 3.046

5.  Uncoupling of 5-HT1A receptors in the brain by estrogens: regional variations in antagonism by ICI 182,780.

Authors:  A L Mize; L J Young; R H Alper
Journal:  Neuropharmacology       Date:  2003-04       Impact factor: 5.250

6.  Estrogen effects on 5-HT1A receptors in hippocampal membranes from ovariectomized rats: functional and binding studies.

Authors:  W P Clarke; S Maayani
Journal:  Brain Res       Date:  1990-06-04       Impact factor: 3.252

7.  Identification of a new class of steroid hormone receptors.

Authors:  V Giguère; N Yang; P Segui; R M Evans
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

8.  Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl] [4-[2-(1-piperidinyl)ethoxy]-phenyl]methanone hydrochloride (LY156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity.

Authors:  C D Jones; M G Jevnikar; A J Pike; M K Peters; L J Black; A R Thompson; J F Falcone; J A Clemens
Journal:  J Med Chem       Date:  1984-08       Impact factor: 7.446

9.  Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins.

Authors:  P Blier; A Lista; C De Montigny
Journal:  J Pharmacol Exp Ther       Date:  1993-04       Impact factor: 4.030

10.  Rapid uncoupling of serotonin-1A receptors in rat hippocampus by 17beta-estradiol in vitro requires protein kinases A and C.

Authors:  Amy L Mize; Richard H Alper
Journal:  Neuroendocrinology       Date:  2002-12       Impact factor: 4.914

View more
  13 in total

1.  Oestrogen modulation of the effect of 8-OH-DPAT on prepulse inhibition: effects of aromatase deficiency and castration in mice.

Authors:  Andrea Gogos; Sally Martin; Margaret E Jones; Maarten van den Buuse
Journal:  Psychopharmacology (Berl)       Date:  2006-08-01       Impact factor: 4.530

Review 2.  Regulation of dorsal raphe nucleus function by serotonin autoreceptors: a behavioral perspective.

Authors:  Ross A McDevitt; John F Neumaier
Journal:  J Chem Neuroanat       Date:  2011-05-08       Impact factor: 3.052

Review 3.  Neuroanatomical dichotomy of sexual behaviors in rodents: a special emphasis on brain serotonin.

Authors:  Mariana Angoa-Pérez; Donald M Kuhn
Journal:  Behav Pharmacol       Date:  2015-09       Impact factor: 2.293

Review 4.  Conceptualizing the role of estrogens and serotonin in the development and maintenance of bulimia nervosa.

Authors:  Tom Hildebrandt; Lauren Alfano; Michelle Tricamo; Donald W Pfaff
Journal:  Clin Psychol Rev       Date:  2010-05-31

Review 5.  Cellular and molecular alterations in mice with deficient and reduced serotonin transporters.

Authors:  Qian Li
Journal:  Mol Neurobiol       Date:  2006-08       Impact factor: 5.590

Review 6.  Sex steroids and the dentate gyrus.

Authors:  Tibor Hajszan; Teresa A Milner; Csaba Leranth
Journal:  Prog Brain Res       Date:  2007       Impact factor: 2.453

7.  Gonadectomy and hormone replacement exert region- and enzyme isoform-specific effects on monoamine oxidase and catechol-O-methyltransferase activity in prefrontal cortex and neostriatum of adult male rats.

Authors:  B Meyers; A D'Agostino; J Walker; M F Kritzer
Journal:  Neuroscience       Date:  2009-11-10       Impact factor: 3.590

Review 8.  Sex hormones and mood in the perimenopause.

Authors:  Peter J Schmidt; David R Rubinow
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 9.  Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia.

Authors:  Mohammad M Khan
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

10.  Modifying 5-HT1A Receptor Gene Expression as a New Target for Antidepressant Therapy.

Authors:  Paul R Albert; Brice Le François
Journal:  Front Neurosci       Date:  2010-06-17       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.